Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Oral Administration of a Novel Small Molecule Blocks the BMP Canonical and the Non-canonical BMP2, BMP4, and BMP5 Signaling Pathways Ameliorates EAE Through Oligodendrogenesis Remyelination and Preservation of Axonal Integrity and Reduces Astrogenesis

              Author:Golan, Maya   Benhamou, Moshe   Fainberg, Karin   Bleich Kimelman, Nadav   Rubnov, Shai   Danon, Uri   Marom, Ehud   Karni, Arnon   

              Session Name:P7: Multiple Sclerosis: Biomarkers, Immunology, and Basic Science  

              Topic:Multiple Sclerosis  

              Program Number:P7.015  

              Author Institution:Tel Aviv Sourasky Medical Center, Tel Aviv, Israel  Tel Aviv University, Tel Aviv, Israel  Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel  Stem Cell Medicice, Nessa Ziona, Israel  Stem Cell Medicine, Ness Ziona, Israel  

              GA Depot (Long-acting IM Injection of Glatiramer Acetate) Presents Improved Safety and Tolerability Features: Results from a Multinational, Double-blind, Placebo-controlled Phase III Study in Subjects with Relapsing Forms of Multiple Sclerosis

              Author:Miller, Aaron   Popper, Laura   Kolb, Hadar   Kimelman, Nadav   Rubnov, Shai   Danon, Uri   Marom, Ehud   

              Session Name:P8: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 1  

              Topic:Multiple Sclerosis  

              Program Number:P8.018  

              Author Institution:Mt Sinai School Of Med, New York, NY  Mapi Pharma Ltd., Ness Ziona, Israel  Souraski Medical Center, Tel Aviv, Israel  Mapi Pharma Ltd, Ness Ziona, Israel